WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1488,794$11.44
$1.02MBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-1314,950$11.63
$173.87kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-128,971$11.86
$106.40kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-119,593$10.95
$105.04kBuy
Venrock Healthcare Capital Partners III LP10% Owner2025-02-10574$10.90
$6.26kBuy
Fairmount Funds Management LLCDirector2024-09-11275,000$23.00
$6.33MBuy
Janus Henderson Group PLC10% Owner2024-08-165,390$2.93
$15.79kBuy
Janus Henderson Group PLC10% Owner2024-08-16428$2.98
$1.27kBuy
Janus Henderson Group PLC10% Owner2024-07-2530,227$3.05
$92.28kBuy
Janus Henderson Group PLC10% Owner2024-07-247,056$3.16
$22.28kBuy

1 of 3

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ravi Viswanathan27.30%10,221,465$113.25MInsider
Forest Baskett27.30%10,221,465$113.25MInsider
Joshua Makower27.30%10,221,465$113.25MInsider
Peter J. Barris27.30%10,221,465$113.25MInsider
Harry R. Weller27.30%10,221,465$113.25MInsider
Anthony A. Florence Jr.27.30%10,221,465$113.25MInsider
Krishna Kittu Kolluri27.30%10,221,465$113.25MInsider
David M. Mott27.30%10,221,465$113.25MInsider
Peter W. Sonsini27.30%10,221,465$113.25MInsider
Jon Sakoda27.30%10,221,465$113.25MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA17.19%82.81%Net Buying
RAPP70.15%29.85%Net BuyingNet Selling
PRTC0.16%0.00%
PGEN22.68%77.32%Net BuyingNet Selling
RGNX76.83%23.17%Net SellingNet Buying
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 84.87% institutional shareholders, 408.80% Oruka Therapeutics insiders, and 0.00% retail investors. Ravi Viswanathan is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 27.30% of the company. Ravi Viswanathan's Oruka Therapeutics shares are currently valued at $113.25M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.